Lopinavir 200 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination utilizes a protease inhibitor boosted with ritonavir to enhance plasma concentrations and antiviral activity, supporting effective control of HIV-1 infection when used within recommended treatment regimens.
Product Details
Therapeutic Class
Protease Inhibitor (Lopinavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered as per standard dosing guidelines or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 Tablets
Lopinavir 200 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination utilizes a protease inhibitor boosted with ritonavir to enhance plasma concentrations and antiviral activity, supporting effective control of HIV-1 infection when used within recommended treatment regimens.
Product Details
Therapeutic Class
Protease Inhibitor (Lopinavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered as per standard dosing guidelines or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 Tablets
Lopinavir 200 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination utilizes a protease inhibitor boosted with ritonavir to enhance plasma concentrations and antiviral activity, supporting effective control of HIV-1 infection when used within recommended treatment regimens.
Product Details
Therapeutic Class
Protease Inhibitor (Lopinavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered as per standard dosing guidelines or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 Tablets